Bottle Label 4 mg (71610 0355 30)
Tizanidine
Product Images NDC 71610-355
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 71610-355). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena Pharma Solutions (TN)
Figure-1.jpg (Figure 1)
This is a figure depicting the mean concentration of Tizanidine over time for both tablets and capsules of 2 x 4mg dosage under fasted and fed conditions.*
Figure-2.jpg (Figure 2)
The text describes a figure labeled as "Figure 2" in a single-dose study. The figure displays the mean change in muscle tone from the baseline, as measured by the Ashworth Scale with a 95% confidence interval. A negative Ashworth score indicates an improvement in muscle tone from the baseline. The unit for hours post-dose is also mentioned in the figure.*
Figure-3.jpg (Figure 3)
Chemical-structure (Tizanidine Imtb 01)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
